A preliminary study on the efficacy and safety of photodynamic therapy in the adjuvant treatment of chronic hyperplastic candidosis

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100042471

Enrollment

Unknown

Registered

2021-01-22

Start date

2021-02-01

Completion date

Unknown

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic hyperplastic candidosis

Interventions

experimental group:Photodynamic Therapy

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Aged >= 18 years, both male and female; 2.Diagnosis of chronic hyperplastic candidosis was established based on clinical, pathological and etiological examination.

Exclusion criteria

Exclusion criteria: 1.History of pregnancy or breast-feeding; 2.Inability to follow the doctor's advice to receive treatment or incomplete records of the trial process, affecting the judgment of efficacy; 3.Contraindications to photodynamic therapy such as hypersensitivity to photosensitizers.

Design outcomes

Primary

Measure	Time frame
The nature of the lesion improved;Increased disease damage area changes;	—

Secondary

Measure	Time frame
Clinical recurrence rate;mycological examination;	—

Countries

China

Contacts

Public ContactYan Zhimin

Department of Oral Medicine, Peking University Hospital of Stomatology

yzhimin96@163.com+86 10 82195439

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026